ECONOMIC MECHANISMS FOR STIMULATING INNOVATION IN THE PHARMACEUTICAL INDUSTRY

The domestic pharmaceutical industry is classified as a highly specific industry. The consequences of the painful transition from the command-administrative system to the market system have had a negative impact on the situation of the domestic pharmaceutical industry. However, in recent years, serious attention has been paid to the current situation by both the state and private investors. One of the most significant growth drivers for the industry today is the development of innovations (development, testing and production of original drugs, innovative pharmaceutical products, orphan drugs, pharmaceutical substances, etc.). In order to develop the emerging and promising trend within the pharmaceutical industry, it is necessary to use effective tools, including economic mechanisms. The paper highlights key aspects that shape the relevance of the modern domestic drug-producing industry development, provides characteristics that shape specific features of the Russian pharmaceutical industry, reflects the difference between the industry's focus on generic products and the production of innovative drugs, considers the concept of "economic mechanisms", highlights methods for stimulating innovative activity in the works of various authors, groups mechanisms for stimulating innovative activity in various sectors of the Russian economy, identifies and formulates mechanisms for stimulating innovation in the pharmaceutical industry (cluster, investment, patent, public-private, state guarantees, educational, credit, tax). The research methods include a method of bibliographic research of publications on the content and structure of components of economic mechanisms for supporting and stimulating innovative activity at enterprises in various sectors of the economy with subsequent synthesis of the identified information, which makes it possible to identify the main types of mechanisms used or possible for use in the Russian pharmaceutical industry. The information base for the study included current publications of authoritative scientists in the problem area under consideration, opinions of leading experts, analytical publications of various information agencies and news feeds.

Authors

Institutions

Publication Details

Journal
Actual directions of scientific researches of the XXI century theory and practice
Published
2025-12-20
DOI
https://doi.org/10.34220/2308-8877-2025-13-5-78-93
Primary Topic
Economic, Social, and Public Health Issues in Russia and Globally
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ECONOMIC MECHANISMS FOR STIMULATING INNOVATION IN THE PHARMACEUTICAL INDUSTRY

A. M. Izmaylov
Actual directions of scientific researches of the XXI century theory and practice
Economic, Social, and Public Health Issues in Russia and Globally
article

ECONOMIC MECHANISMS FOR STIMULATING INNOVATION IN THE PHARMACEUTICAL INDUSTRY

A. M. Izmaylov
article en

Abstract

The domestic pharmaceutical industry is classified as a highly specific industry. The consequences of the painful transition from the command-administrative system to the market system have had a negative impact on the situation of the domestic pharmaceutical industry. However, in recent years, serious attention has been paid to the current situation by both the state and private investors. One of the most significant growth drivers for the industry today is the development of innovations (development, testing and production of original drugs, innovative pharmaceutical products, orphan drugs, pharmaceutical substances, etc.). In order to develop the emerging and promising trend within the pharmaceutical industry, it is necessary to use effective tools, including economic mechanisms. The paper highlights key aspects that shape the relevance of the modern domestic drug-producing industry development, provides characteristics that shape specific features of the Russian pharmaceutical industry, reflects the difference between the industry's focus on generic products and the production of innovative drugs, considers the concept of "economic mechanisms", highlights methods for stimulating innovative activity in the works of various authors, groups mechanisms for stimulating innovative activity in various sectors of the Russian economy, identifies and formulates mechanisms for stimulating innovation in the pharmaceutical industry (cluster, investment, patent, public-private, state guarantees, educational, credit, tax). The research methods include a method of bibliographic research of publications on the content and structure of components of economic mechanisms for supporting and stimulating innovative activity at enterprises in various sectors of the economy with subsequent synthesis of the identified information, which makes it possible to identify the main types of mechanisms used or possible for use in the Russian pharmaceutical industry. The information base for the study included current publications of authoritative scientists in the problem area under consideration, opinions of leading experts, analytical publications of various information agencies and news feeds.

Actual directions of scientific researches of the XXI century theory and practiceVol. 13(5)
Samara State Medical University (RU), Povolzhskiy State University of Telecommunications and Informatics (RU)
Industry, innovation and infrastructure
Openalex Percentile: Top 30%
Economic, Social, and Public Health Issues in Russia and Globally
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.